Your browser doesn't support javascript.
loading
Effect of Rosuvastatin Therapy on Biomarkers of Inflammation and Immune Activation in People With Human Immunodeficiency Virus at Intermediate Cardiovascular Risk.
Hearps, Anna C; Angelovich, Thomas A; Trevillyan, Janine M; Wong, Michelle E; Calmy, Alexandra; Hoy, Jennifer F; Jaworowski, Anthony.
Afiliação
  • Hearps AC; Life Sciences Discipline, Burnet Institute, Melbourne, Victoria, Australia.
  • Angelovich TA; Department of Infectious Diseases, The Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
  • Trevillyan JM; Life Sciences Discipline, Burnet Institute, Melbourne, Victoria, Australia.
  • Wong ME; School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia.
  • Calmy A; Department of Infectious Diseases, The Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
  • Hoy JF; Life Sciences Discipline, Burnet Institute, Melbourne, Victoria, Australia.
  • Jaworowski A; Central Clinical School, Monash University, Melbourne, Victoria, Australia.
J Infect Dis ; 224(4): 667-672, 2021 08 16.
Article em En | MEDLINE | ID: mdl-34398237
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Infecções por HIV / Inibidores de Hidroximetilglutaril-CoA Redutases / Rosuvastatina Cálcica Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Infecções por HIV / Inibidores de Hidroximetilglutaril-CoA Redutases / Rosuvastatina Cálcica Idioma: En Ano de publicação: 2021 Tipo de documento: Article